Drugs / (RS)2-(3-benzoylphenyl)-propionic acid
last change Apr 2015 re-read 3 minutes ago

(RS)2-(3-benzoylphenyl)-propionic acid

Developed for
lymphedema
Investigated by
Stanford University

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01893879 Apr 2014 → Apr 2015 lymphedema Stanford University Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as (RS)2-(3-benzoylphenyl)-propionic acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT01893879 ↗
Route Oral “Given PO” NCT01893879 ↗